UroGen Pharma: Targeting Profits In 2027

The biotech sector is chock full of attractive covered call opportunities for those that know what equities to target. Option premiums on stocks in this high beta sector tend to be lucrative, and many provide good liquidity as well. Live Chat on The Biotech Forum frequently discusses solid covered call opportunities on selected biotech stocks. Join our community at The Biotech Forum by clicking HERE .Today, I am putting UroGen Pharma Ltd. ( NASDAQ: URGN ) in the spotlight for the first time since my last ar ...